Ovid Therapeutics Inc. · NASDAQ:OVID
ADAR1 Capital Management, LLC's stake in Ovid Therapeutics Inc. fell to 5.10% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
ADAR1 Capital Management, LLC's stake in Ovid Therapeutics Inc. fell to 5.10%, 9,559,979 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 5.10%
- Shares
- 9,559,979
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| ADAR1 Capital Management, LLC | 5.10% | 9,559,979 |
| ADAR1 Capital Management GP, LLC | 4.90% | 9,122,588 |
| Daniel Schneeberger | 5.10% | 9,559,979 |
Source
Related
- Ovid Therapeutics Inc.
- ADAR1 Capital Management, LLC
- Ovid Therapeutics Inc. shareholders
- Schedule 13G · ADAR1 Capital Management, LLC · Feb 17, 2026
- Schedule 13G/A · Eventide Asset Management, LLC · Aug 14, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2026
- Schedule 13G/A · Balyasny Asset Management L.P. · Aug 14, 2026
- Schedule 13G/A · Affinity Asset Advisors, LLC · Aug 13, 2026
- Schedule 13G · BlackRock, Inc. · Jul 29, 2026